Black Diamond Therapeutics shares owned by Bellevue Group
Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Bellevue Group
from 13F filings
Historical chart of Bellevue Group investment in Black Diamond Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Black Diamond Therapeutics held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Black Diamond Therapeutics by Bellevue Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $37M | 8.5M | 4.35 |
| 2024-06-30 | $40M | 8.5M | 4.66 |
| 2024-03-31 | $43M | 8.5M | 5.07 |
| 2023-12-31 | $24M | 8.5M | 2.81 |
| 2023-09-30 | $23M | 8.1M | 2.87 |
| 2023-06-30 | $41M | 8.1M | 5.05 |
| 2023-03-31 | $10M | 5.4M | 1.89 |
| 2022-12-31 | $9.7M | 5.4M | 1.80 |
| 2022-09-30 | $8.0M | 4.7M | 1.69 |
| 2022-06-30 | $12M | 4.7M | 2.48 |
| 2022-03-31 | $9.2M | 3.3M | 2.78 |
| 2021-12-31 | $19M | 3.5M | 5.35 |
| 2021-09-30 | $29M | 3.5M | 8.48 |
| 2021-06-30 | $42M | 3.5M | 12.17 |
| 2021-03-31 | $54M | 2.2M | 24.23 |
| 2020-12-31 | $45M | 1.4M | 32.08 |
| 2020-09-30 | $42M | 1.4M | 30.23 |
| 2020-06-30 | $59M | 1.4M | 42.15 |
| 2020-03-31 | $33M | 1.3M | 24.95 |